Global Diabetic Neuropathy Market 2014-2018

2014-05-09
Price :
Published : May-2014
No. of Pages : 55

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Over-the-Counter Drug Market 2016-2020

OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores. The analysts forecast global over-the-counter (OTC) drug market to grow at a CAGR of 6.19% during the period 2016-2020. Covered in this report The report covers present scenario and the growth prospects of the global over-the-counter (OTC) drug market for 2016-2020. To calculate the market size, t......
$2500

Global Premature Ejaculation Treatment Market 2016-2020

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient's relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes. The analyst forecast global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.......
$2500

Global Parenteral Products Packaging Market 2016-2020

Parenteral packaging refers as an economical means of providing protection, presentation, identification, information, and convenience for parenteral products from the moment of production until it is used to the injectable route of drug administration. The sterility of the drug inside the container is essential as parenteral drugs are injected directly into the body tissue. So, packaging should protect and avoid any physical, chemical and biological contamination of the drug during the opening of the packaging. The common packaging material used for parenteral packaging are made of glass and plastic. The primary parenteral packaging for dosing and filling includes ampules, tubes, vials, inhalers, and syringes. The analyst forecast global parenteral products packaging market to grow at ......
$2500

Global Pain Management Drugs Market 2016-2020

Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain. The analyst forecast global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global pain management drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from th......
$2500

Global Pneumococcal Vaccine Market 2016-2020

Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen. The analyst forecast global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 20......
$2500

Global Biosimilars Market 2016-2020

Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator's product. They have many similarities, but are not identical to, the reference biopharmaceutical product. The analyst forecast global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoiet......
$2500

Global Emergency Contraceptive Pills Market 2016-2020

EC pills are short-term contraceptives used in the initial days after sexual intercourse to prevent pregnancy due to various uncertainties such as unprotected intercourse, coerced sex, forgotten pills, and condom breakage. These pills are only effective before the fertilization of the ovum by the sperm. As per WHO, levonorgestrel-based EC pills are ideal for users when taken in a single dose. These pills are not effective after five days once the ovulation process begins. Factors such as urbanization, increasing acceptance of sex, and growing visibility of EC pills are increasing their penetration in emerging economies. The analyst forecast global EC pills market to grow at a CAGR of 1.93% during the period 2016-2020. Covered in this report This report covers the present scenario ......
$2500

Global Asthma Therapeutics Market 2016-2020

Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period. The analyst forecast global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020. Covered in th......
$2500

Global Medical Membranes Market 2016-2020

Medical membranes are majorly used for separation of the feed stream. The feed stream is passed through the membrane, which allows selective constituents to pass through, depending on its pore size, whereas others are stopped back on the surface of the membrane. The elements that pass through are known as permeate and the ones that are retained back are known as concentrate. Different types of membranes are used in the medical industry depending on the size of their pores. The analyst forecast global medical membranes market to grow at a CAGR of 9.61% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global medical membranes market for 2016-2020. The report also presents the vendor landscape and a correspond......
$2500

Global Testosterone Replacement Therapy Market 2016-2020

Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs. The analyst forecast global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global testosterone replacement th......
$2500